Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ PASK Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA521879
Description
Recommended positive controls: 293T, H1299, HepG2, Molt-4, Raji. Predicted reactivity: Mouse (83%), Rat (82%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
PASK is an evolutionarily conserved protein present in yeast, flies, and mammals. PAS domains regulate the function of many intracellular signaling pathways in response to both extrinsic and intrinsic stimuli. It is a conserved gene product found in yeast as well as mammals. PASKIN contains two domains (PAS A and PAS B) as well as a serine/threonine kinase domain related to AMP kinases. PASKIN activity leads to decreased carbohydrate storage, as well as increased protein synthesis. PASKIN-dependent phosphorylation inhibits the activity of mammalian glycogen synthase.
Specifications
| PASK | |
| Polyclonal | |
| Unconjugated | |
| PASK | |
| Kiaa0135; mKIAA0135; OTTMUSP00000024404; PAS domain containing serine/threonine kinase; PAS domain-containing serine/threonine-protein kinase; PASK; PASKIN; PAS-kinase; per-arnt-sim (PAS) domain kinase; STK37 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 23178 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Western Blot | |
| 0.87 mg/mL | |
| 0.1M tris glycine with 10% glycerol and 0.01% thimerosal; pH 7 | |
| Q96RG2 | |
| PASK | |
| Recombinant protein encompassing a sequence within the C-terminus region of human PASK. The exact sequence is proprietary. | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction